S 932 · 119th Congress 2025–2027

Give Kids a Chance Act of 2025

Latest action · Mar 11, 2025 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 11, 2025
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Give Kids a Chance Act of 2025

This bill authorizes certain targeted clinical trials involving combinations of drugs to treat pediatric cancer, and renews the Food and Drug Administration’s (FDA’s) authority to award priority review vouchers (PRVs) to sponsors of new products for rare pediatric diseases.

Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs used in combination with active ingredients that have already been approved and that (1) have been determined to be part of the standard of care for treating a pediatric cancer, or (2) have been approved to treat an adult cancer and are directed at molecular targets for pediatric cancer.

The FDA must issue guidance on the implementation of these provisions and report to Congress on its efforts to ensure implementation. The Government Accountability Office (GAO) must report on the effectiveness of the bill's changes with respect to the development of pediatric cancer drugs.

The bill also renews the FDA’s authority to issue PRVs to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029. This is known as the Rare Pediatric Disease PRV program. The program expired in December 2024.

GAO must report on the effectiveness of the Rare Pediatric Disease PRV program, including to what extent PRVs were successful in promoting drug development and expediting patient access to drugs for the treatment or prevention of rare pediatric diseases.

Cosponsors 20

Members who signed on, in the order they did. Signatures ran from Mar 11, 2025 to Nov 19, 2025; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-COMichael F. BennetOriginalMar 11, 2025
D-MNAmy KlobucharApr 4, 2025
D-NHJeanne ShaheenApr 4, 2025
R-KSRoger MarshallApr 4, 2025
R-FLRick ScottApr 8, 2025
R-MESusan M. CollinsApr 8, 2025
D-NJAndy KimOct 23, 2025
D-DEChristopher A. CoonsOct 23, 2025
R-OHJon HustedOct 23, 2025
D-AZMark KellyOct 23, 2025
R-WVShelley Moore CapitoOct 23, 2025
R-MTTim SheehyOct 23, 2025
R-FLAshley MoodyOct 30, 2025
D-COJohn W. HickenlooperOct 30, 2025
R-ARJohn BoozmanNov 6, 2025
D-ILTammy DuckworthNov 6, 2025
D-CAAdam B. SchiffNov 18, 2025
D-RIJack ReedNov 18, 2025
R-LAJohn KennedyNov 18, 2025
R-MOEric SchmittNov 19, 2025

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateHealth, Education, Labor, and Pensions Committee
Referred Mar 11, 2025

Actions 2

Everything that happened, newest first.

  1. Mar 11, 2025Introduced in Senate
  2. Mar 11, 2025Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Related bills 5

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 891Bipartisan Health Care ActRelated billMar 6, 2025
HR 1262Mikaela Naylon Give Kids a Chance ActRelated billDec 2, 2025
HR 1768Lower Costs for Everyday Americans ActRelated billMar 3, 2025
S 3302Mikaela Naylon Give Kids a Chance Act of 2025Related billDec 2, 2025
HR 7148Consolidated Appropriations Act, 2026Related billFeb 3, 2026

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.
Short Title(s) as Introduced
Give Kids a Chance Act of 2025

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Mar 11, 2025Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.